These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16764655)

  • 1. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Liu FT; Ueno H
    Clin Exp Ophthalmol; 2006; 34(4):347-53. PubMed ID: 16764655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice.
    Fukushima A; Ozaki A; Jian Z; Ishida W; Fukata K; Ueno H; Liu FT
    Curr Eye Res; 2005 Apr; 30(4):241-8. PubMed ID: 15823916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction.
    Shii D; Nakagawa S; Shinomiya K; Yoshimi M; Katsuta O; Oda T; Nakamura M
    Curr Eye Res; 2009 Jun; 34(6):426-37. PubMed ID: 19899977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Taniguchi T; Liu FT; Ueno H
    Exp Eye Res; 2006 Feb; 82(2):210-8. PubMed ID: 16102751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.
    Fukushima A; Yamaguchi T; Ozaki A; Taniguchi T; Udaka K; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1043-9. PubMed ID: 15838661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of VLA-4 in the development of allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
    Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
    Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial tears inhibit the development of experimental immune-mediated blepharoconjunctivitis.
    Fukushima A; Zinchuk O; Ueno H
    Jpn J Ophthalmol; 2004; 48(6):530-4. PubMed ID: 15592776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
    Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ozaki A; Ueno H
    Immunol Lett; 2005 Sep; 100(2):189-94. PubMed ID: 15919119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
    Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.
    Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Koyanagi A; Koyama N; Yagita H
    Immunol Lett; 2008 Dec; 121(2):140-7. PubMed ID: 19027794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ag-specific recognition, activation, and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis.
    Fukushima A; Ozaki A; Fukata K; Ishida W; Ueno H
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4366-74. PubMed ID: 14507881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of FK506 on the development of experimental allergic/immune-mediated blepharoconjunctivitis in Lewis rats by systemic but not by topical administration.
    Iwamoto H; Yoshida H; Yoshida O; Fukushima A; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):407-14. PubMed ID: 10333108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
    Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
    Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Roles of cytokines in the development of severe allergic conjunctival diseases: analyses using animal models].
    Fukushima A
    Nippon Ganka Gakkai Zasshi; 2004 Nov; 108(11):682-9. PubMed ID: 15584353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T cells play disparate roles in the induction and the effector phases of murine experimental allergic conjunctivitis.
    Fukushima A; Yamaguchi T; Fukuda K; Sumi T; Kumagai N; Nishida T; Imai S; Ueno H
    Microbiol Immunol; 2006; 50(9):719-28. PubMed ID: 16985294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of cyclosporine a eye drops on symptoms in late phase and delayed-type reactions in allergic conjunctivitis models.
    Shii D; Nakagawa S; Yoshimi M; Katsuta O; Oda T; Nakamura M
    Biol Pharm Bull; 2010; 33(8):1314-8. PubMed ID: 20686224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast-cell activation augments the late phase reaction in experimental immune-mediated blepharoconjunctivitis.
    Ozaki A; Fukushima A; Fukata K; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2003 May; 241(5):394-402. PubMed ID: 12682842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.